|
|
|
|
|
In Bladder Cancer, Listen to Patients and Prioritize Quality of Initial Management
|
|
Ashish Kamat, MD, MBBS
|
| Bladder cancer is a chronic condition, and early management plays a critical role in patients' outcomes and quality of life. The Global Bladder Cancer Patient & Carer Survey highlights the need to improve primary care providers and public awareness of bladder cancer risk factors, which can lead to timely diagnosis. Delayed diagnosis and treatment can result in worse outcomes and increased financial toxicity for patients.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEER-TO-PEER CLINICAL CONVERSATIONS
|
|
|
|
|
|
|
Bladder Cancer's Impact on Daily Life and Employment: A Global Perspective
|
Lori Funk-Cirefice, and Lydia Makaroff, Ph.D.
Ashish Kamat is joined by Lori Cirefice and Lydia Makaroff who discuss the findings of the Global World Bladder Cancer Patient Coalition Survey, focusing on the impact of bladder cancer on daily life and caregivers. The survey, which garnered nearly 1,200 responses from 45 countries, reveals significant financial and emotional strain on patients and their carers.
|
|
|
|
|
|
|
|
|
|
|
|
Global Insights into Bladder Cancer Care: A Comprehensive Survey by the World Bladder Cancer Patient Coalition
|
Patrick Hensley, MD, and Lydia Makaroff, Ph.D.
Ashish Kamat is joined by Pat Hensley and Lydia Makaroff, who share insights into patient experiences and treatment access. Drs. Hensley and Makaroff delve into the findings of the Global Bladder Cancer Patient and Care Experience survey, conducted by the World Bladder Cancer Patient Coalition.
|
|
|
|
|
|
|
|
|
|
|
|
The Global Bladder Cancer Survey: A Strategic Analysis of Diagnosis and Care
|
Stephanie Demkiw, B.Med, B.Surg, B.Biomed Sci, and Lydia Makaroff, PhD
Ashish Kamat discusses the World Bladder Cancer Patient Coalition's Bladder Cancer Patient and Carer Experience Survey with Stephanie Demkiw and Lydia Makaroff. The survey reveals that awareness of bladder cancer symptoms is low, with over half of the respondents unaware of the signs before diagnosis.
|
|
|
|
|
|
|
|
|
|
|
| Bladder Preservation in Muscle Invasive Bladder Cancer: Myth or Reality
|
| Jason Efstathiou, MD, and Maria Ribal, MD, Ph.D.
|
| Shilpa Gupta moderates a debate on whether bladder preservation in muscle-invasive bladder cancer is a myth or reality. Dr. Jason Efstathiou advocates for trimodality therapy, highlighting that it is an important surgical approach for select patients, supported by guidelines, and can achieve outcomes comparable to radical cystectomy with good long-term quality of life. Maria Ribal argues for radical cystectomy, emphasizing that trimodality therapy is only suitable for a small percentage of patients, and cost-effectiveness and patient selection criteria must be considered.
|
|
|
|
|
|
|
|
|
|
|
| Prospective Comparative Study of Quality of Life in Bladder Cancer Patients Undergoing Cystectomy or Bladder Preservation
|
| Vedang Murthy, MD, DNB, DipEPP
|
| Vedang Murthy presents a study comparing the quality of life in bladder cancer patients undergoing radical cystectomy versus bladder preservation. The research involved 104 patients with muscle-invasive bladder cancer, and the results showed that there were no significant differences in functional, global health, and symptom scales between the two groups.
|
|
|
|
|
|
| Evaluation of Gender-Specific Differences in Health-Related Quality of Life for Bladder Cancer Patients After Radical Cystectomy - Results From a Large Prospective Propensity Score-Matched Cohort
|
| Severin Rodler, MD
|
| Severin Rodler discusses a study focused on gender-specific differences in health-related quality of life for bladder cancer patients after radical cystectomy. It identified disparities in HRQoL following RC between men and women. Women experienced significantly worse general HRQoL compared to men, especially during long-term follow-up.
|
|
|
|
|
|
|
|
|
|
|
|
